Literature DB >> 10535986

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.

C Kurts1, R M Sutherland, G Davey, M Li, A M Lew, E Blanas, F R Carbone, J F Miller, W R Heath.   

Abstract

There are two major mechanisms reported to prevent the autoreactivity of islet-specific CD8(+) T cells: ignorance and tolerance. When ignorance is operative, naïve autoreactive CD8(+) T cells ignore islet antigens and recirculate without causing damage, unless activated by an external stimulus. In the case of tolerance, CD8(+) T cells are deleted. Which factor(s) contributes to each particular outcome was previously unknown. Here, we demonstrate that the concentration of self antigen determines which mechanism operates. When ovalbumin (OVA) was expressed at a relatively low concentration in the pancreatic islets of transgenic mice, there was no detectable cross-presentation, and the CD8(+) T cell compartment remained ignorant of OVA. In mice expressing higher doses of OVA, cross-presentation was detectable and led to peripheral deletion of OVA-specific CD8(+) T cells. When cross-presentation was prevented by reconstituting the bone marrow compartment with cells incapable of presenting OVA, deletional tolerance was converted to ignorance. Thus, the immune system uses two strategies to avoid CD8(+) T cell-mediated autoimmunity: for high dose antigens, it deletes autoreactive T cells, whereas for lower dose antigens, it relies on ignorance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535986      PMCID: PMC23058          DOI: 10.1073/pnas.96.22.12703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Ontogeny of T cell tolerance to peripherally expressed antigens.

Authors:  D J Morgan; C Kurts; H T Kreuwel; K L Holst; W R Heath; L A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Induction of autoimmune diabetes by oral administration of autoantigen.

Authors:  E Blanas; F R Carbone; J Allison; J F Miller; W R Heath
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

3.  Constitutive class I-restricted exogenous presentation of self antigens in vivo.

Authors:  C Kurts; W R Heath; F R Carbone; J Allison; J F Miller; H Kosaka
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Determination of lymphocyte division by flow cytometry.

Authors:  A B Lyons; C R Parish
Journal:  J Immunol Methods       Date:  1994-05-02       Impact factor: 2.303

5.  A new method for isolation of murine islets with markedly improved yields.

Authors:  M Liu; M E Shapiro
Journal:  Transplant Proc       Date:  1995-12       Impact factor: 1.066

6.  Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.

Authors:  M B Oldstone; M Nerenberg; P Southern; J Price; H Lewicki
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

8.  Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells.

Authors:  T E Adams; S Alpert; D Hanahan
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

9.  Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells.

Authors:  D Lo; J Freedman; S Hesse; R D Palmiter; R L Brinster; L A Sherman
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

10.  Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.

Authors:  F R Carbone; M W Moore; J M Sheil; M J Bevan
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  57 in total

1.  Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen.

Authors:  C E Touloukian; W W Leitner; P F Robbins; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 2.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

Review 3.  Transplant tolerance: models, concepts and facts.

Authors:  Nicola J Monk; Roseanna E G Hargreaves; Elizabeth Simpson; Julian P Dyson; Stipo Jurcevic
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

4.  Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.

Authors:  Ian A Parish; Jason Waithman; Gayle M Davey; Gabrielle T Belz; Justine D Mintern; Christian Kurts; Robyn M Sutherland; Francis R Carbone; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 5.  Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.

Authors:  Maurizio Zanetti; Xavier Hernandez; Pierre Langlade-Demoyen
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

6.  Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.

Authors:  Vinod Singh; Qingyong Ji; Lionel Feigenbaum; Robert M Leighty; Arthur A Hurwitz
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

Review 7.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

Review 8.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

9.  Impaired thymic selection and abnormal antigen-specific T cell responses in Foxn1(Δ/Δ) mutant mice.

Authors:  Shiyun Xiao; Nancy R Manley
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

10.  Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.

Authors:  Eric F Tewalt; Jean M Grant; Erica L Granger; Douglas C Palmer; Neal D Heuss; Dale S Gregerson; Nicholas P Restifo; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.